Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan dose-response in healthy subjects
NCT02078973Phase 2Completed
- Sponsor
- Regionshospitalet Holstebro
- Start
- Mar 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolvaptan in nephropathy, sponsored by Regionshospitalet Holstebro. Started Mar 2014; status: completed.
02
Drugs
tolvaptan
03
Conditions
nephropathy
Beyond the preview
Go deeper on NCT02078973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02078973.